Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Daily vs Intermittent Chemotherapy for HIV-TB
NCT00933790Phase 3Completed
- Sponsor
- National Institute for Research in Tuberculosis
- Start
- Sep 2009
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of rifampicin, isoniazid, ethambutol, pyrazinamide in pulmonary tuberculosis (TB), sponsored by National Institute for Research in Tuberculosis. Started Sep 2009; status: completed.
02
Drugs
rifampicinisoniazidethambutolpyrazinamide
03
Conditions
pulmonary tuberculosis (TB)
Beyond the preview
Go deeper on NCT00933790.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00933790.